Chengdu Kanghua Biological Products (300841) Stock Overview

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.